Health Care & Life Sciences » Pharmaceuticals | ASKA Pharmaceutical Co. Ltd.

ASKA Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
947
1,688
1,448
3,300
3,063
1,883
Depreciation, Depletion & Amortization
2,459
1,815
2,057
2,501
2,394
2,618
Other Funds
2,180
209
1,157
221
2,153
279
Funds from Operations
1,226
3,294
2,348
6,027
3,302
4,780
Changes in Working Capital
1,390
2,415
3,697
6,036
3,226
2,276
Net Operating Cash Flow
2,616
5,709
1,349
12,063
76
2,504
Capital Expenditures
2,007
2,126
5,605
733
1,510
Purchase/Sale of Investments
435
270
852
839
2,202
Net Investing Cash Flow
2,301
1,897
6,776
378
3,348
Cash Dividends Paid - Total
388
389
389
390
392
Issuance/Reduction of Debt, Net
224
191
4,342
2,008
750
Net Financing Cash Flow
574
557
4,013
2,384
1,142
Net Change in Cash
259
3,255
4,112
9,301
4,414
Free Cash Flow
798
3,764
3,646
11,373
668
Other Sources
141
-
-
-
364
Change in Capital Stock
38
23
60
13
-
Other Uses
-
41
319
483
-

About ASKA Pharmaceutical Co.

View Profile
Address
2-5-1 Shibaura
Tokyo Tokyo 108
Japan
Employees -
Website http://www.aska-pharma.co.jp
Updated 07/08/2019
ASKA Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceuticals,veterinary medicines,quasi-drugs,foods,and medical devices. It operates through the following business division: Research and Development. The Research and Development division provides new medicine in R&D system with a balanced combination of cutting-edge pharmaceutical technology and a long experience, to grow and expand persistently as a medium R&D company focusing on a specialized field.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.